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Summary: We consider the problem of optimally designing Lot Quality Assurance Sampling (LQAS) plans for
health monitoring purposes. A Mixed Integer Nonlinear Programming (MINLP) formulation is proposed to address
the problem when pre-defined levels of accuracy of diagnostic metrics used to assess the programmes are imposed.
The formulation is used for finding LQAS plans for different combinations of diagnostic metrics which are compared
to classic plans based on purely statistical backgrounds.
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1. Introduction
A Lot Quality Assurance Sampling (LQAS) is a classification procedure for decision making
about the acceptance of a given lot. The strategy is grounded in the statistical tools developed
around 1920-30 to help control the quality from a production line. LQAS was developed in the
1950’s for the industry to check product quality and quickly found wide-spread applications in
health care surveys. Robertson and Valadez (2006) provides a review of LQAS and illustrates
how it can help decision makers classify a given population characteristic as acceptable or
not. Lemeshow and Taber (1991) provides statistical details and also compares merits of
having a single or double-sampling plan.
LQAS is commonly used in public health research to determine if a health policy or
a community program is working for the intended purpose. Some specific applications of
LQAS are monitoring immunization programmes to ascertain their cost effectiveness (San-
diford, 1993), monitoring elimination leprosy in a region (Gupte et al., 2004), examining
effectiveness of community intervention programs of captia and management systems on
maternal and child health behavior change (Valadez et al., 2005), assessing the prevalence
of acute malnutrition (Deitchler et al., 2007; Olives et al., 2009; Olives and Pagano, 2010)
and monitoring malaria outcome indicators (Biedron et al., 2010). Vanamail et al. (2006)
discussed operation feasibility and implementation of LQAS as a tool for routine monitoring
in the context of filariasis control programs. LQAS invariably includes design questions; given
user-specified decision parameters for the problem, what are the optimal sample size and the
decision rules to implement for, say, monitoring the effectiveness of a disease eradication
community based program or a state-sponsored vaccination program? Interest in LQAS
continues to date. For example, Olives et al. (2012) applied ideas to incorporate outcomes
that have a few categories, not just two, with application to Schistosomiasis control.
The design of LQAS plans for health monitoring is similar to Acceptance Sampling plans by
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variables or attributes for quality control purposes. Both can be formulated as optimization
problems (Duarte and Saraiva, 2008, 2013), which frequently require the minimization of
certain quantities, such as the sample size or the Average Sampling Number (ASN) subject
to the constraints at the controlled points of the operating characteristic (OC) curve.
Very often the health monitoring programmes are intended to reach a previously defined
level of a statistical measure quantifying the performance of the binary classification test.
Among the vast number of diagnosis performance metrics, the most used are: (i.) Specificity ;
(ii.) Sensitivity ; (iii.) Negative Predicted Value (NPV); and (iv.) Positive Predictive Value
(PPV). For a review of the diagnostic performance metrics the reader is referred to Altman
and Bland (1994); Fletcher et al. (2012) and in §2.2 we review the definitions commonly
accepted in biostatistics community.
Despite of the advantages of the LQAS plans based on controlling two points lying to
the OC curve which are easier to find and are tabulated, when a diagnosis accuracy metric
is previously established it would be beneficial implementing LQAS plans specifically for
that purpose. While the first are based on purely statistical knowledge, the second accounts
for the specific goals of the monitoring health programmes. From our knowledge this topic
has never been investigated, and in this paper we propose the first systematic approach for
designing LQAS plans to meet pre-defined levels of diagnosis performance metrics.
The paper includes four additional sections. In Section 2, the mathematical background
that supports our approach is presented. Section 3 introduces the MINLP formulation for
designing LQAS plans to satisfy the OC-curve constraints and diagnosis performance criteria.
In section 4 we present and compare results, and in Section 5 we conclude.
2. Mathematical background
In this section, we provide the background material required for the formulation and nu-
merical solution of LQAS plan design problem. In section 2.1 we introduce LQAS plans, in
Design of LQAS plans to meet diagnostic accuracy metrics 3
§2.2 we introduce the diagnosis performance metrics, in §2.3 we review the use of Gaussian
Quadrature Formulas (GQF), and in section 2.4, we briefly review the fundamentals of
MINLP.
2.1 LQAS plans
This section presents the fundamentals of Acceptance Sampling. Following convention, we
use the binomial distribution to model the probability of individuals having the characteristic
ξ in the population where ξ can model outcomes as “having a disease”/“having not a disease”
or “having been vaccinated”/“having not been vaccinated” among others depending on the
program monitoring purpose. In the former scenario “having not a disease” is represented
with ξ = 1 and the opposite outcome by ξ = 0. In the latest context, ξ = 1 is to represent the
outcome “having been vaccinated” and ξ = 0 the opposite result. Practically, the result of the
test on each individual is either conforming or nonconforming, with the former corresponding
the individual having the sought characteristic, i.e. a success with ξ = 1. Throughout, we
make two assumptions: (i) the probability of selecting nonconforming/conforming individuals
is independent of the sampling method; and (ii) the potentially infinite number of individuals
of the population is not impacted by the sample.
We represent a sampling plan by S(n, r), where n is the sample size and r is the acceptance
limit used to declare a lot/population acceptable (or not) based on a binary outcome ξ taking
values 0 or 1. A primary goal is to assure that the lot or population is acceptable when the
proportion of outcomes ξ meets a given conformity proportion. The procedure randomly
samples n individuals and the population/lot is accepted if the number of individuals in
the sample tested positive (ξ = 1) is greater or equal to r. Otherwise, the population/lot
is declared unacceptable. Since the decision is based on testing a particular hypothesis, the
inference is subject to statistical type I and II error rates. To measure the classification
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errors we use the probability of acceptance of lots/populations with a given proportion p of
successes, denoted by Pa(p).
Very often the LQAS plans are designed to reach pre-specified levels of risk of misclassi-
fication of populations/lots at required lower and upper proportions of success, pL and pU ,
respectively. The constraints imposed to the plan are grounded on statistical knowledge,
and require that the probability of incorrectly classify a lot of upper quality level pU as
unacceptable (type I error) should be lower than α, and the probability of incorrectly classify
a lot of lower quality pL as acceptable (type II error) should be lower than β, i.e.
P (x > r|pL) 6 β (1a)
and P (x > r|pU) > 1− α. (1b)
Here x is the number of individuals of the population/lot with the sought characteristic (i.e.
ξ = 1) and P (x > r|pL) is the probability of considering the population/lot acceptable for a
given proportion level of successes pL.
The probability of obtaining a specified number x of individuals with the sought characte-
ristic in a sample of n from a population with a proportion p having the characteristic ξ = 1
is modeled by the binomial distribution
P(x) =
(
n
x
)
px (1− p)n−x, x = 0, · · · , n. (2)
If the number of conforming individuals tested (with ξ = 1) in the sample is less than r,
we reject the population/lot and conclude that the programme was not succeed, otherwise
we accept the population and infer that the programme is well succeed. In public health
research, we may want to ascertain if the people are adequately vaccinated in a region, and
so x in such a study is the number of people vaccinated in the sample.
The OC curve represents the probability of acceptance of populations/lots with a given
proportion p of individuals with ξ = 1. For acceptance/rejection purposes of populations
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tested for a characteristic following the binomial distribution (2), the OC curve is
F (p|n, r) =
n∑
x=r
P(x) =
n∑
x=r
(
n
x
)
px (1− p)n−x, (3)
which is computed using the regularized Beta function, here denoted by I, see Press et al.
(1996, Chap. 6) for details:
F (p|n, r) =
n∑
x=r
(
n
x
)
px (1− p)n−x = I(p, n− r, r − 1). (4)
One of the early strategies used to design LQAS plans is based on the OC curve. In
practice, the sample size and the acceptance constant are determined such that the conditions
F (pL|n, r) 6 β and F (pU |n, r) > 1 − α are both validated for pre-defined levels pL and pU
and risks α and β. In spite of the decision grey region pL 6 p 6 pU being the interval where
the consequences of the misclassification error have lower impact, there are recognized risks
that are not accounted for in the LQAS plans. In particular, LQAS plans may have good
sensitivity but not good specificity (Sandiford, 1993).
2.2 Diagnosis performance metrics
Diagnostic tests where the result is binary are conventionally summarized in a two-by-
two table (Fletcher et al., 2012). The corresponding diagnostic accuracy tests is commonly
measured by some metrics; among them are (i) Sensitivity; (ii) Specificity; (iii) PPV; and
(iv) NPV. Formal definitions of the diagnosis performance metrics for binary outcome tests
summarized in two-by-two contingency tables are, respectively (Griner et al., 1981):
Spec. =
TP
TP + FN
, (5a)
Sens. =
TN
TN + FP
, (5b)
NPV =
TN
TN + FN
(5c)
PPV =
TP
TP + FP
(5d)
Here, TP is the number of individuals with ξ = 1 that test positive (desirable outcome),
FN is the number of individuals with ξ = 1 that test negative (undesirable outcome), FP
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is the number of individuals with ξ = 0 that test positive (undesirable outcome), and TN
is the number of individuals with ξ = 0 that test negative (desirable outcome). Specificity
is the proportion of individuals with ξ = 1 correctly identified, Sensitivity is the proportion
of individuals with ξ = 0 correctly identified, NPV the proportion of individuals that test
negative correctly identified, and PPV is the proportion of individuals that test positive
correctly identified. In what follows, we use the formal definitions (5) adapted to three-by-
two Table 1. The elements of the three-by-two Table 1 are the number of individuals (or
its proportion) that test negative or positive for different proportion of success where the
grey zone is an additional scenario. Table 2 combined with equations (6) set the metrics
for lots/populations with low proportion of individuals with ξ = 1 (p 6 pL) and large
proportion (p > pU). In what is to follow, we call the proportion of individuals with
ξ = 1 as the anticipated prevalence, as Lemeshow and Taber (1991). Typically, we have
low anticipated prevalence rate (LAPR) populations and high anticipated prevalence rate
(HAPR) populations if p 6 pL and p > pU , respectively.
[Table 1 about here.]
[Table 2 about here.]
a =
∫ pL
0
n∑
x=r
(
n
x
)
px (1− p)n−x dp b =
∫ pU
pL
n∑
x=r
(
n
x
)
px (1− p)n−x dp (6a)
c =
∫ 1
pU
n∑
x=r
(
n
x
)
px (1− p)n−x dp d =
∫ pL
0
r−1∑
x=0
(
n
x
)
px (1− p)n−x dp (6b)
e =
∫ pU
pL
r−1∑
x=0
(
n
x
)
px (1− p)n−x dp f =
∫ 1
pU
r−1∑
x=0
(
n
x
)
px (1− p)n−x dp (6c)
2.3 Gaussian Quadrature Formulas
Gaussian Quadrature Formulas are a class of methods that use appropriate weights and
nodes to numerically integrate a complex function f(t) to a high degree of accuracy. For a
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one dimension integral over an arbitrary compact interval [a, b], the formula is:
∫ b
a
w(t) f(t)dt
.
=
M∑
j=1
wj f(tj)
where w(t) is a weighting function, and M is the number of points, also designated as nodes,
used in the integration. The accuracy of the approximation of the integral as a sum depends
on the selected weight wj at the nodes tj. A major advantage of GQF is that with judicious
choices of the nodes and weights, it needs only M points to exactly integrate polynomials of
degree 2 M −1 or less. This means that only M evaluations of the function f(t) are required
(Gerald and Wheatley, 1994). For w(t) = 1, a = −1 and b = 1 the nodes correspond to the
zeros of the M th order Legendre polynomials; see, for example, Atkinson (1989). For w(t) = 1
and an arbitrary compact interval on the real line, the weights and nodes are determined
from recursive algorithms such as those presented in Davis and Rabinowitz (1984). The
numerical approximations of the integrals (6) obtained using GQF are:
a =
pL
2
M∑
j=1
[
1− I
(
tj
pL
2
+
pL
2
, n− r, r − 1
)]
wj (7a)
b =
pU − pL
2
M∑
j=1
[
1− I
(
tj
pU − pL
2
+
pU + pL
2
, n− r, r − 1
)]
wj (7b)
c =
1− pU
2
M∑
j=1
[
1− I
(
tj
1− pU
2
+
1 + pU
2
, n− r, r − 1
)]
wj (7c)
d =
pL
2
M∑
j=1
I
(
tj
pL
2
+
pL
2
, n− r, r − 1
)
wj (7d)
e =
pU − pL
2
M∑
j=1
I
(
tj
pU − pL
2
+
pU + pL
2
, n− r, r − 1
)
wj (7e)
f =
1− pU
2
M∑
j=1
I
(
tj
1− pU
2
+
1 + pU
2
, n− r, r − 1
)
wj (7f)
where tj are the zeros of the Legendre polynomials in [−1, 1] and wj are the weights. In all
calculations presented in subsequent sections we consider M = 20.
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2.4 Mixed Integer Nonlinear Programming
Mixed Integer Nonlinear Programming refers to a class of optimization problems including
continuous and discrete variables and nonlinear functions in the objective function and/or
the constraints. Mixed Integer Nonlinear Programs (MINLPs) arise in a wide range of
applications, including chemical engineering, finance, and management. The general form
of a MINLP is
min
x,y
f(x,y) (8a)
s.t. hi(x,y) = 0, ∀i ∈ E (8b)
gi(x,y) 6 0, ∀i ∈ I (8c)
x ∈ X, y ∈ Y (8d)
where each function hi(x,y) and gi(x,y) is a mapping from Rn to R, E is the set of equality
constraints, I the set of inequalities, X ∈ Rn is a continuous compact domain, Y is discrete
domain containing integer values, x is the set of continuous variables and y the set of integer
variables.
The most commonly used algorithms used to solve MINLPs are the outer approximation
(Duran and Grossmann, 1986), the branch and bound (Fletcher and Leyffer, 1998) and
the extended cutting plane (Westerlund and Pettersson, 1995). For the fundamentals of
MINLP and the algorithms the reader is referred to Floudas (2002). All the problems
addressed in the paper are solved with a branch and bound algorithm using the solver
SBB (GAMS Development Corporation, 2013b) available within the general modeling system
GAMS 24.2.1 (GAMS Development Corporation, 2013a). SBB combines the standard branch
and bound method known from Mixed Integer Linear Programming and a standard NLP
solver supported by GAMS 24.2.1. Here CONOPT is used for solving the relaxed nonlinear
programs (Drud, 1985) and CPLEX is used for solving local integer linear programs (GAMS
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Development Corporation, 2013b). The relative tolerance used in all problems is 10−5. In our
design context the variables a, b, c, d, e and f are continuous; and n and r are integer. All
computation in this paper were carried using on an Intel Core i7 machine (Intel Corporation,
Santa Clara, CA) running 64 bits Windows 10 operating system with 2.80 GHz.
3. Optimal LQAS formulations
In this section we introduce the MINLP formulations for designing LQAS plans. In Section
3.1 we address the problem of finding a LQAS plan that assures that the conditions (1)
at the controlled points of the OC curve are satisfied, and in §3.2 we consider the problem
of designing plans for a combination of diagnosis performance criteria where lower bound
thresholds are assumed. The former problem will be designated as the OC curve-constrained
design problem and the later as the performance criteria-constrained design problem. In
both cases the objective is the minimization of the sample size which has an economic
impact. Typically, the algorithms used to design OC curve-constrained LQAS plans stand
on enumerative procedures where n and r are successively iterated until the constraints at
the controlled points of the OC curve are both satisfied (Lemeshow and Taber, 1991).
3.1 Formulation for OC curve-constrained LQAS plans
We consider that the risks α and β and the target proportions required for LAPR and HAPR
populations are imposed. The resulting MINLP minimizes the sample size providing that the
conditions (1) are satisfied. Equation (4) is used to represent the OC curve. The optimization
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problem is as follows:
min
n,r
n (9a)
s.t. I(pU , n− r, r − 1) > 1− α (9b)
I(pL, n− r, r − 1) 6 β (9c)
n > 2 (9d)
r > 1 (9e)
n, r ∈ N (9f)
where equations (9b-9c) are the constraints at the OC points, (9d) and (9e) are lower bounds
for n and r imposed by rational reasons.
3.2 Formulation for performance-constrained LQAS plans
Here, we consider that the targets for some of the diagnosis performance criteria listed in
§2.2 are known. Let us designate the target for Sensitivity for populations with a LAPR of
ξ = 1 as σL, the target to apply in populations with HAPR of individuals with ξ = 1 as σU ;
the target for Specificity for LAPR environments as θL, the target for HAPR scenarios as θU ;
the target for PPV for LAPR environments as piL and the target for HAPR environments as
piU . Finally, we designate the target for NPV for LAPR environments as %L and the target for
HAPR environments as %U . The reformulation of the criteria in Table 2 to avoid fractionary
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terms produces the performance constraints later included in the design problem:
Sensitivity for LAPR a > σL(a+ d) (10a)
Sensitivity for HAPR f > σU(c+ f) (10b)
Specificity for LAPR e+ f > θL(b+ c+ e+ f) (10c)
Specificity for HAPR a+ b > θU(a+ b+ c+ d) (10d)
PPV for LAPR a > piL(a+ b+ c) (10e)
PPV for HAPR f > piU(d+ e+ f) (10f)
NPV for LAPR e+ f > %L(d+ e+ f) (10g)
NPV for HAPR a+ b > %U(a+ b+ c) (10h)
Following, the relations (7) together with a combination of constraints (10) chosen to
construct LQAS plans to meet a given combination of diagnosis accuracy metrics are used
to formulate the performance criteria-constrained design problem:
min
n,r
n (11a)
s.t. Equations (7) (11b)
Combination of equations (10) (11c)
n > 2 (11d)
r > 1 (11e)
n, r ∈ N (11f)
a, b, c, d, e, f ∈ [0, 1] (11g)
Let us demonstrate our approach with an example where we want to find the LQAS plan to
reach a given level of Sensitivity for LAPR populations, σL, and for HAPR lots/populations,
σU . The problem (11) includes the relations (7) and the constraint (11c) aggregates the
constraints for Specificity (10a-10b). The problems for other criteria or criteria combination
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are constructed similarly. Notice that in some cases the criteria might be antagonistic which
may produce infeasible solutions which are also detected by the proposed formulation. This
topic will be further analyzed in §4.
4. Results
In this section we present the results for the OC curve-constrained design problem and
compare them with those obtained for the performance criteria-constrained design problem
for different combinations of performance criteria.
To test the formulation (9) for optimally designing LQAS plans we consider a scenario
where α = β = 0.10 and pL and pU are varied in a region commonly used in practical
studies. In all scenarios the difference between pU and pL is kept constant but different
values are considered. Table 3 presents the results and we observe that as the proportions
for LAPR and HAPR populations increase, larger is the ratio r/n, and more discriminant
is the plan. The results obtained are in good agreement with those of Lemeshow and Taber
(1991). All examples presented in following tables require less than 1.0 s of CPU time which
proves the numerical efficiency of the algorithm.
Figure 1 presents the OC curves for optimal plans obtained for scenarios S1 and S5. They
illustrate the constraints satisfaction for both setups, and the larger discriminant power of
the plan obtained for S5. We observe that both OC curves pass below the point (pL, β) and
above the point (pU , 1 − α) as required by the formulation. For the error rates considered
(α = β = 0.1), both plans are constrained at the point (pL, β).
[Table 3 about here.]
[Figure 1 about here.]
Table 4 presents the LQAS for several combinations of diagnosis performance criteria. The
same trend observed for OC curve constrained plans applies here; as the proportions assumed
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for LAPR and HAPR increase, the discrimination of the plans increases as well as the ratio
r/n.
To analyze the optimality of the solutions of the performance criteria-constrained design
problem let us consider the LQAS plan obtained for scenario S5 when both the criteria
sensitivity for LAPR and for HAPR are to be met (line 5 of Table 4). The OC curve of the
plan S(6, 4) is presented in Figure 2, which also depicts the areas a, b, c, d, e and f . Table
5 lists the values of the areas and the Specificity for both groups, and we observe that the
constraints (a/(a+ d) > σL and f/(c+ f) > σU) are satisfied.
[Table 4 about here.]
[Figure 2 about here.]
[Table 5 about here.]
Our results demonstrate that for some specific anticipated prevalence proportions (pL
and pU), particular combinations of diagnosis performance metrics and lower bounds, the
optimization problem is infeasible and there is not an LQAS plan satisfying all constraints
simultaneously. When the solution of (11) can not be obtained because of the antagonistic
characteristics of the constraints, the feasibility of a relaxed problem including not the
integral terms is checked with another mathematical program. That is, we convert the
inequalities (10) into equivalent equalities and solve a square system of 6 algebraic equations
with respect to a, b, c, d, e and f using the solver CNS (GAMS Development Corporation,
2013b) included in GAMS 24.2.1. CNS is for constrained nonlinear systems and uses the
nonlinear programming solver CONOPT.
Besides the relations between the parameters required by the constraints on the diagnosis
metrics, others derived from geometrical assumptions using Figure 2, e.g. a+d = pL, b+e =
pU − pL, c+ f = 1− pU and a+ d+ b+ e+ c+ f = 1, can be derived. The possible results
of the procedure are: (i) a combination of a, b, c, d, e and f exists and the original design
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problem is feasible; and (ii) there is not a combination of a, b, c, d, e and f and the design
is infeasible. In this case, lower values of threshold bounds must be used.
To demonstrate the use of this check tool let us consider the LQAS plan obtained for the
setup where the design criteria are the Specificity for LAPR and Specificity for HAPR (second
line in Table 4) and the threshold level is 0.95 for both criteria, i.e. θU = θL = 0.95, pL = 0.6
and pU = 0.9. The mathematical programming problem solved to check the feasibility of the
design problem is
find a, b, c, d, e, f (12a)
s.t a+ b = θL(a+ b+ d+ e) (12b)
e+ f = θU(b+ c+ e+ f) (12c)
a+ d = pL (12d)
b+ e = pU − pL (12e)
c+ f = 1− pU (12f)
a+ b+ c+ d+ e+ f = 1 (12g)
a, b, c, d, e, f ∈ [0, 1]. (12h)
The model (12) is infeasible, and consequently, an LQAS plan satisfying the constraints
cannot be found. In practice, the maximum value of θU and θL that make the problem feasible
for θL = θU is 0.7692. If we allow θU 6= θL, then for θU = 0.95, the maximum value of θL
that produces a feasible plan is 0.6888. These findings are dependent of the values assumed
for pL and pU .
5. Conclusions
We propose MINLP formulations to handle the problem of designing LQAS plans for imple-
menting in health monitoring programmes. The design problem consists of minimizing the
sample size such that a set of constraints are satisfied. First, we consider the design problem
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using the classic framework where the constraints result from the points controlled of the
OC curve. Next, we propose a formulation where the constraints result from a combination
of diagnosis performance criteria the plan are sought to guarantee. As far as we know, our
formulation is the first that can be used to design LQAS to meet pre-defined levels of diagnosis
performance criteria. The later formulation requires numerically calculating integrals and
we use 20-point based GQF for such a purpose. We test our proposed formulations for a
large range of setups and diagnosis accuracy criteria combinations, and compare the results.
Finally, we analyze cases where the combination of diagnosis performance criteria can not
be satisfied simultaneously, and a feasible plan can not be found. In this case, we propose
a linear programming formulation to check the feasibility of the LQAS design problem for
that combination of anticipated prevalence proportions and threshold bounds.
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Figure 1. OC curves for LQAS plans obtained for scenarios S1 and S5 employing the OC
curve-constrained design problem formulation (α = β =0.1).
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Figure 2. OC curve for LQAS plan obtained with the performance criteria-constrained
design problem formulation for scenario S5 when the target for Sensitivity for LAPR and for
HAPR populations is imposed (σU = σL = 0.95, pL = 0.6, pU = 0.9).
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Table 1
Outcomes of the LQAS plan.
Proportion of individuals with ξ = 1 in the population
0 6 p 6 pL pL 6 p 6 pU pU 6 p 6 1.0
Test Outcome (ξ)
0 a b c
1 d e f
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Table 2
Diagnosis metrics for different prevalence rates of individuals with ξ = 1 in the population.
Anticipated prevalence
Low rate (p = pL) High rate (p = pU )
Performance
metrics
Sens. a
a+d
f
c+f
Spec. e+f
b+c+e+f
a+b
a+b+d+e
PPV a
a+b+c
f
d+e+f
NPV e+f
d+e+f
a+b
a+b+c
Design of LQAS plans to meet diagnostic accuracy metrics 23
Table 3
LQAS plans obtained with the OC curve-constrained design problem formulation (α = β =0.1).
Scenario pL pU n r
S1 0.40 0.70 25 13
S2 0.45 0.75 23 13
S3 0.50 0.80 21 13
S4 0.55 0.85 21 14
S5 0.60 0.90 18 13
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Table 4
LQAS plans obtained with the performance criteria-constrained design problem formulation.
Combination of criteria Scenario pL pU n r
Sensitivity for LAPR & S1 0.40 0.70 8 4
Sensitivity for HAPR S2 0.45 0.75 9 5
(Constraints: (10a,10b)) S3 0.50 0.80 7 4
(σU = σL = 0.95) S4 0.55 0.85 8 5
S5 0.60 0.90 6 4
Specificity for LAPR & S1 0.40 0.70 12 6
Specificity for HAPR S2 0.45 0.75 13 7
(Constraints: (10c,10d)) S3 0.50 0.80 17 10
(θU = θL = 0.75) S4 0.55 0.85 13 8
S5 0.60 0.90 18 12
Sensitivity for LAPR & S1 0.40 0.70 3 2
Specificity for HAPR S2 0.45 0.75 3 2
(Constraints: (10a,10d)) S3 0.50 0.80 3 2
(θU = 0.75, σL = 0.95) S4 0.55 0.85 3 2
S5 0.60 0.90 4 3
PPV for LAPR & S1 0.40 0.70 4 2
PPV for HAPR S2 0.45 0.75 5 3
(Constraints: (10e,10f)) S3 0.50 0.80 4 3
(piU = piL = 0.6) S4 0.55 0.85 5 4
S5 0.60 0.90 8 7
NPV for LAPR & S1 0.40 0.70 6 3
NPV for HAPR S2 0.45 0.75 7 4
(Constraints: (10g,10h)) S3 0.50 0.80 6 4
(%U = %L = 0.95) S4 0.55 0.85 7 5
S5 0.60 0.90 5 4
PPV for LAPR & S1 0.40 0.70 4 2
NPV for LAPR S2 0.45 0.75 5 3
(Constraints: (10e,10g)) S3 0.50 0.80 4 3
(piL = 0.6, %L = 0.95) S4 0.55 0.85 5 4
S5 0.60 0.90 5 4
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